Development of novel targeted therapy for hepatocellular carcinoma
Ended Project Grant Awarded Last action
- Award ID
- R43CA224642
- Recipient
-
Sophia Bioscience, Inc. UEI HEPWWVBLM4C5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- Atlanta, GA 30332, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA224642?
R43CA224642 was awarded to Sophia Bioscience, Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2018.
How much is award R43CA224642 worth?
$300,000 has been obligated on R43CA224642.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award